Q2 FY26 results reported
As filed · Outcome of Board Meeting
EarningsMajormateriality 75 out of 100
What happened
FactFor Dr. Agarwal’s Health Care Limited.
Why it matters
CapitSignal interpretationReported results are the point at which prior management commitments become checkable against audited or reviewed numbers.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Debt
RevisedEarlierQ1 FY27
finance cost actually moved from about close to INR24.7 crores in Q1 of last year to about close to INR23.5 crores.
NowQ1 FY27
the interest on deferred acquisition payable was about close to INR6.8 crores in corresponding quarter of last year, which dropped down to about INR3.6 crores.
Change
FactTarget revision
Implication
CapitSignal interpretationThe stated figure moved -72.47%.confidence 60%
Watch next
Fact- Margin trend against the prior period
- Cash from operations against reported profit
- Whether prior guidance is reaffirmed
- We expect to clock 20% plus revenue growth in FY '26, driven by strengthening presence in existing micro-marke (management committed by FY26)
- We also expect the profit after tax numbers to rise by 35% plus. (management committed by FY26)
Evidence
- Dr. Agarwal's Health Care Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.(opens the original filing in a new tab)
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
- Earlier statement · Q1 FY27
How CapitSignal classified this
- Reasoning:
- RESULTS base 68; +2 corroborating keywords; +5 quantified amount; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%